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Previous studies have shown that lymphocytes
from renal allografted patients with a good function-
ing graft display donor-specific cell-mediated lym-
pholysis nonreactivity (CML-NR) in vitro. To define
whether the HLA System influences the occurrence
of the CML-NR, immunogenetic studies were carried
out. Posttransplant lymphocytes derived from CML-
NR patients were stimulated in vitro with lympho-
cytes from unrelated healthy blood donors, who
were selected for the presence or absence of kidney
donor-specific HLA antigens. The presentation of
kidney donor-specific HLA-B (and -C) antigens on
the lymphocytes of unrelated blood donors resulted
in cytolytic nonresponsiveness, whereas presenta-
tion of the kidney donor-specific HLA-A locus anti-
gens on lymphocytes of the unrelated blood donors
revealed no cytolytic nonresponsiveness. The re-
sults, as displayed by posttransplant lymphocytes
of renal allografted patients, demonstrate that the
kidney donor HLA-B (and -C) antigens are responsi-
ble for the in vitro-observed, donor-specific CML-
NR. Consequently, presentation of cells from panel
members matched to the kidney donor at the HLA-
B locus suppresses the response towards HLA-A
locus antigens. The in vitro-observed cytolytic non-
responsiveness appeared not to be due to an ab-
sence of specific cytotoxic Τ lymphocytes, because
the nonresponsiveness can be abrogated by addi-
tion of exogenous IL 2.
The cell-mediated lympholysis (CML)2 technique is orte
of the cellular test Systems that may be used as an in
vitro reflection of the in vivo allograft reaction. Immu-
nologie tolerance, as manifested by allograft aeeeptance,
may be correlated in vitro with the absence of host
cytotoxic Τ lymphocytes (CTL) speeifieally directed
against the graft histocompatibility antigens. The devel-
opment of posttransplant cell-mediated lympholysis non-
reactivity (CML-NR) in reeipients of HLA-non-identical
related and unrelated donor kidneys has been docu-
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mented in several reports (1-11). In a previous study ol
82 related donor/reeipient combinations, we reported
that the failure of reeipients' lymphocytes to elicit in vitro
cytotoxic response against the kidney donor splenocytes
(in 70% of the nonrejeeting renal allografted reeipients]
correlated significantly with good kidney allograft func-
tion (6).
The development of specific anti-donor CML-NR aftcr
transplantation is presumably a complex of cellular and
humoral events. Several mechanisms such as involve-
ment of suppressor cells (11-13) or anti-idiotypic anti-
bodies that inhibit speeifieally the proliferative responses
in mixed lymphocyte eultures (MLC) against the kidney
donor alloantigens (14, 15) have been suggested to ac-
count for this phenomenon.
To increase our insights into the mechanism(s) in-
volved in the posttransplant development of donor-spe-
cific CML-NR, we investigated the cytolytic repertoire of
reeipients' lymphocytes. Immunogenetic studies were
carried out to define more precisely the influence of the
HLA System on the occurrence of CML-NR.
Consequently, the specific cytotoxic response of the
reeipients' lymphocytes towards a selected panel of un-
related blood donors as specific stimulator target cells
was measured. Α drastically diminished cytotoxic activity
was observed against the kidney donor-specific HLA-B
(and -C) antigens when presented on lymphocytes from
unrelated blood donors. Furthermore, normal levels of
cytolytic activity could be restored through the addition
of exogenous interleukin 2 (IL 2) or by the use of HLA-B
(and -C) mismatched stimulator cells.
MATERIALS AND METHODS
From a group of 82 unrelated donor/reeipient combinations. 51
patients became CML-NR (after successful kidney transplantation)
against the splenocytes of their specific kidney donor (6). Immuno-
genetic studies were performed by using the lymphocytes of 16 of
these 51 CML-NR patients at different time intervals posttransplan-
tation and of three patients with CML reactivity against the specific
kidney donor splenocytes.
Table I lists the match grades of these patients with their respec-
tive kidney donors. The three CML reactiue patients included pa-
tients 17, 18. and 19. Patient 17 rejeeted the graft; the lymphocytes
obtained after graft nephrectomy showed CML reactivity against the
specific kidney donor splenocytes. Lymphocytes from patient 18
showed donor-specific CML-reactivity 3 yr posttransplant. this pa-
tient had a funetioning graft. Patient 19 developed specific kidney
donor CML-NR only after 200 days posttransplantation, immuno-
genetic studies have been carried out with lymphocytes obtained
during both CML-reactive and CML-nonreactive (day 500) penods.
All patients had received blood transfusions before kidney trans-
plantation, they received a first cadaveric graft under the auspices
of Eurotransplant.
Protocol immunogenetic studies. Posttransplant lymphocytes of
16 CML-NR patients and of three CML-reactive patients were stim-
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Immunogenetic Study^
Total number of selected
stlmulator cells tested
9
10
9
6
6
5
14
17
10
7
5
15
18
11
10
9
7
5
11
" Lymphocytes from each patient have been stimulated in vitro with
lymphocytes denved from different unrelated healthy blood donors
* =, compatibility
c
 <* incompatibility
TABLE ΙΪ
immimogeneiic protocoi example qf stimulator ceil selection
Patient (P)
Kidney donor
Seierted stimulator cells"
1 A=, B=, C=, DR=
2 A=, B=, C=, DR*
3 A=, B=, C*
4 A* B=,C=
5 A#, B=. C*
6 A=, B". C=
7 A= B", C
8 Α", Β" C=
9 A» B#, C
Α
1, W33
1,3
1.3
1, 3
1,3
1, 2
3,32
1,3
1, 3
2 28
23,25
HLA Typing
Β
37. 58
37,35
37, 35
3 5
37,35
37,35
3 5
37,57
40,35
7, 13
18,45
C
w 3
w6
w 6
w 6
w4
w 3
w4
w6
w2, w4
w6
w 5
DR
1
1, 5
1.5
2 , 3
1, 7
4
1, 8
1, 7
4, 6
1, 2
2, 7
α
 =, matched ", mismatched with the kidney donor for HLA-A, -B. -C.
or -DR antigens The availabihty of 10,000 HLA-A,-B,-C typed individuals
in the Department of Immunohematology and Bloodbank, Leiden, facili-
tated the stimulator cell selection
ulated in vitro against specific kidney donor splenocytes and selected
stimulator cells from healthy unrelated blood donors matched or
mismatched with the kidney donor for the HLA-A, -B, or -C antigens
and combinations thereof (see Table I) Stimulator cells were consid-
ered as matrhed for a specificity when sphts and/or main specifici-
ties were ldentical, l e , B7-B7, B44-B44; BJ4-B14, Bw57-Bw57
Mismatches were considered stimulator cells with different main
specificities or other sphts of the same specificity, ι e , Β7-Β8, B44-
1545, B14-B8, Bw57-Bw58 An example of the immunogenetic pro-
loeol is shown in Table II It demonstrates the selection of stimulator
cells from healthy unrelated blood donors matched or mismatched
with the kidney donor for HLA-A, -B, or -C antigens and combina-
•ions thereof
To control the responder capacity of the lymphocytes of CML-NR
patients and stimulator capacity of the selected stimulator cells,
vmphocytes from unrelated healthy individuals (HLA-A, -B, -C. and
DR identical to the patient) were stimuiated with the same array ol
stimulator cells (see above) on the same day in the same expenment
)f a given patient Kidney donor lymphocytes were obtained from
he spieen and used without density centnfugation All blood sam-
ples, ι e , the patient's lymphocytes, the kidney donor splenocytes,
ind the lymphocytes of the HLA-A, -B, -C, and -DR compatible and
mcompatible unrelated healthy blood donors, were frozen and stored
η liquid mtrogen until tested
The responder/sümulator cell combinations, as mentioned above,
vere cultured for 6 days Depending on the amount of lymphocytes
ivailable either tissue culture flasks or 2 ml cluster wells were used
\ftcr the c ulture penod, the effector cells were tested in the standaid
^ML assay against their specific stimulator cells as target cells
The CML assay has been descnbed in detail (16) The percentages
>f lysis were determmed in relation to phytohemagglutimn-stimu-
lated blast cells in a 4-hr 5lCr assay Cytotoxicity (ι e , the amount of
isotope released from 51Cr labeled target cells) was determined and
calculated accordmg to the descnbed method (16) Standard errors
of the mean of tnphcate determinations were less than 5% Positive
and negative assignments were made on the basis of a 10% specific
51Cr-release value. All expenments were repeated at least twice at
dtfferent effector to target ratios Prolonged growth of some effector
cells populations was performed with the use of commercially avail-
able IL 2 (T cell growth factor containing a residual amount of ± 150
ng PHA/ml. Biotest Cat. no. 812800), an appropnate final concen-
tration is 20% in the culture medium. Α prehmmary report on the
immunogenetic studies of five other CML-NR patients has appeared
elsewhere(17) Typing for HLA-A, -B, and -C antigens was performed
with the Standard lymphocytotoxicity techmque (18), typing for the
HLA-DR antigens was performed with the two-color fluorescence
test(19).
RESULTS
Posttransplant lymphocytes from 16 CML-NR patients
have been analyzed for their specific cytolytic capacity
against selected stimulator cells of unrelated, healthy
blood donors. As already mentioned {Materials and
Methods), the selection of the stimulator cells was based
on the sharing of HLA-A, -B, -C, or -DR antigens, or
combinations thereof, with the specific kidney donor.
Table III shows the CML results of the 19 patients
studied in the immunogenetic protocoi. Posttransplant
patient's lymphocytes were stimulated in vitro with the
specific kidney donor splenocytes and with a series of
selected stimulator cells, and thereafter were tested
against the specific target cells. The results of only one
responder/stimulator cell combination per patient are
shown in the table. As expected, none of the patients 1
to 16 showed CML activity against the specific kidney
donor splenocytes. Absence of cytolytic activity of pa-
tient's lymphocytes was also observed after specific Stim-
ulation with stimulator cells 1,2,3, and 4, and in several
cases with stimulator cells 5. The common denominator
TABLE III
Immunogenetic analysis of the CML nonreactwity in 19 patients
tested posttransplantation
Stlmulator/target cells"
A= A= A= A# Α* Α= Α= Α* Α"
B= B= B= B= B= Β " Β " Β# Β*
C= C= C C= C# C= C# C= C"
DR= DR"
Responder cells
Pl
P2
P3
P4
P5
P6
P7
P8
P9
P10
Pll
P12
P13
P14
P15
P16
P17
P18
P19"
P19°
" Results of only orte responder/stimulator cell c ombination are shown
b
 Kd = kidney donor
' Percentdge of specifir lysis at an effec tor targel ratio ol 50 1
" Pl 9 first bleedmg 200 days posttransplantation
'P19 second bleeding500 days posttransplantation
•'Not tested
Kd"
0 c
1
1
1
5
7
9
4
3
6
3
0
0
0
10
10
99
38
48
7
1
2
N T '
4
0
0
NT
2
NT
7
0
NT
NT
8
4
6
NT
NT
NT
NT
jto
2
7
NT
0
2
NT
NT
7
NT
0
3
NT
8
8
2
NT
10
92
22
62
6
3
10
0
8
5
6
NT
0
1
4
6
NT
NT
4
0
1
NT
96
2 7
79
10
4
Ϊ 6
0
10
3
4
0
0
7
5
NT
3
10
6
0
8
1
88
4 3
37
6
5
5 8
20
3
8
6
NT
I
20
27
10
NT
9
10
2
37
13
56
51
3 9
16
6
3 5
6 5
47
12
NT
24
4 8
56
21
0
NT
27
3 0
NT
6 4
4 8
NT
48
59
61
7
7 2
47
22
41
18
29
5 6
59
55
4 2
48
55
2 8
37
2 8
61
NT
56
62
46
8
81
27
40
6 5
47
49
54
37
20
31
NT
37
6 8
NT
19
4 8
NT
71
NT
NT
9
6 1
40
34
2 9
39
83
3 8
6fe
39
7 3
27
37
5 5
24
3 9
2 5
92
64
70
54
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among stimulator cells 1 through 5 and the kidney donor
was that they all carried the same HLA-B (or -B and -C)
antigens as present on the specific kidney donor.
On the contrary, positive CML reactions were obtained
when patients' lymphocytes were stimulated with stim-
ulator cells 6 to 9. None of the latter stimulator cells
carried the same HLA-B (or -B and -C) antigens as present
on the specific kidney donor.
Lymphocytes from CML-reactive patients 17 to 19
were used as positive controls. The posttransplant lym-
phocytes from these patients showed cytotoxic activity
against both the specific kidney donor splenocytes and
all (i.e., 1 to 9) stimulator cells tested. Patient 19 had
been bled twice. Patient's lymphocytes from the first
bleedmg (i.e., 200 days posttransplantation) showed cy-
tolytic activity against the specific kidney donor spleno-
cytes, as well as against all stimulator cells. The second
bleeding (i.e., 500 days posttransplantation) showed do-
nor-specific CML-NR, and consequently also the absence
of cytotoxic activity after Stimulation with stimulator
cells 1 to 4. The immunogenetic studies with lymphocytes
from four different patients (i.e., P7, P8, P12, and P13,
Table III) have been enlarged by "control combinations"
(see Materials and Methods).
The reaction patterns of the lymphocytes from each
patient were compared with the cytotoxic activity ob-
tained with lymphocytes from healthy individuals who
were HLA-A, -B, -C, and -DR identical to the patient (see
Materials and Methods}. Normal levels of cytotoxic ac-
tivity to all stimulator/target cells were observed (Table
IV).
To further establish the immunogenetic requirements
that are associated with CML-NR, cells from unrelated
individuals with different HLA-A, -B, and -C antigens
have been selected in each group of stimulator cells (i.e.,
1 to 9), and used to stimulate the posttransplant patient's
TABLE IV
Comparison of patterns of cytotoxic activity between the lymphocytes
qj four patients (P) and the lymphocytes qf unrelated mdtviduals (X)
who are HLA identical to these patients upon Stimulation with
kidney donor cetls or cells selectedjor the presence or absence
qf kidney donor HLA antigens
Stimulator/Target Cells"
A= A= A= A# Α» Α= Α= Α» Α*
B= B= B= B= Β- Β# Β» B* B#
C= C= C* C= 0» C= C# C= C»
DR= DR»
Responder cells Kdc _1_ _2
P7" ~TP _2 _7
X 50 23 17
_2 -J Λ J> _Z _3 _?
_0 _0 _J_ 48 56 54 38
27 23 27 44 49 54 39
P8
X
P12
X
P13
X
4 NT' NT _J_ _7
44 NT NT 25 25
20 56
33 67
59
79
37
47
66
54
0 NT _8 fJT K) _9 27 55 37 37
23 NT 19 NT 25 27 35 63 42 33
0 __8
55 38 29 28
_6
37 38
30
25
28 68 55
24 50 60
α
 The specific stimulator cells/specific target cells were selected for the
presence (=) or absence (») of the kidney donor-spec iflc antigens In most
cases more than one stimulator cell in each group (ι e , 1 lo 9) has been
studied The results of only one responder/sümulator cell combinaüon
are shown in this table
" Responder cells P7 = patient 7, responder cells X = unrelated healthy
individuell, HLA-A -B, -C, and -DR identical to each patient
' Kd = kidney donor
'' Percentage specific lysis
' Not tested
lymphocytes. Table V summarizes the total number i,<
stimulator cells that have been tested in each selected
group against the lymphocytes of 16 CML-NR recipients
Table VI compares the total number of CML-positive and
-negative reactions obtained after Stimulation ol »,,
tients' lymphocytes with lymphocytes from healthy blo<xi
donors that were matched vs the donor-specific spk-no
cytes for HLA-B, (and -B and -C) or mismatched for HLA
B, (and -B and -C) locus antigens. It is clear that a ströme
influence on CML-NR (p = 0.0001) is found in the groups
of stimulator cells that were selected for the presence ol
the HLA-B, or -B and -C antigens, as expressed on the
specific kidney donor cells.
One of the possible mechanisms that might explain the
HLA-dependent, donor-specific CML-NR is clonal dele-
tion. To answer the question as to whether donor-specif κ
CTL were indeed absent, we expanded the 6 day effector
cell eultures of lymphocytes from 10 CML-NR patients
against the specific kidney donor splenocytes by the ad-
dition of IL 2. In nine out of 10 of the latter effector cell
combinations, kidney donor-specific CTL were observed
In addition, the lymphocytes of two CML-NR patients
were stimulated aecording the immunogenetic protoeol
and were subsequently expanded. The results of these
experiments are shown in Table VII. Two Short eulture
cycles with the addition of exogenous IL 2 resulted in
detectable levels of cytotoxic activity, as well as responses
against the specific kidney donor splenocytes similar to
TABLE V
Analysis qf CML aetwity qf posttransplant patients' lymphocytes
against stimulator cells selectedjor the presence (or absence) qf tlu
kidney donor HLA antigens
Selected
Stimulator Cells/
Target Cells
1 A=B=C=DR=
2 A=B=C=DR#
3 A=B=C*
4 A*B=C=
5 A»B=C»
6 A=B#C=
7 A=B*C»
8 A*B»C=
9 A»B*C
Total Number
of Stimulator
Cells Tested
10
11
15
2 5
22
18
36
16
2 5
CML responses of post
transplant
patient s lymphocvtesa
+
0
0
1
3
13
14
34
16
2 5
-
b
10
11
14
2 2
9
4
2
0
0
" Posttransplant lymphocytes from 16 CML-NR patients were stimu
lated with a number of stimulator cells selected on the HLA typing of the
original kidney donor (see Materials and Methods)
"Positive and negative assignments were made on the basis of a 10Ύ
51Cr-release value
TABLE VI
CML responses of posttransplant lymphocytes qj renal alloqraji
patients
Selected
Stimulator
Cell used
CML
Response" SelectedStimulator
Cell used
CML
Response"
HLA-A= and
HLA-A and -C=
HLA-A» and
HLA-A and C»
49
32
41
31
2
 = 0 20
3 = 0 65
HLA-B= and
HLA-B and -C=
HLA-B» and
HLA-B and -C»
X2 = 76 72
p = 0 00001
17
64
66
"Total number of positive and negative CML reactions obtained with
posttransplant lymphocytes from 16 CML-NR patients that were stimu
lated with lymphocytes selected lor the present e or absence of the kidney
donor HLA antigens
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TABLE VII
Reappearance of donor specißc CTL by addition oj IL 2
Stimulator/Target Cells
A= A= A= Α " A*
B= B= B= B= B=
C= C= C* C= C "
DR= DR*
A= A= Α» A*
Β* Β" Β* B #
c= c* c= c
Responder cells Kd" 1 2 3 4 _5 _6 _7 _8 _9
P8° Τ 1 1 ' 1 1 15 60 49 51 39
P8 + II 2" 58 54 NT 48 83 76 65 61 60 69
P13
P13 + 1L 2
3 6 NT 8 10 9 28 36 48 66
70 30 NT 29 72 51 55 77 65 82
α
 Kd = kidncy donor
6
 Lymphocytes from patient 8 (P8) have been stimulated with a senes
of different stimulator cells (ι e kidney donor splenocytes and stimulator
cells 1 to 9) see also Materials and Melhods
c
 P8 + IL 2 prolonged growth of the 6 day effector cell population was
carned out
d
 Percentage specific lysis at an effector target ratio of 50 1
' Not tested
the response agamst selected stimulator cells 1, 3, 4, and
5 These results indicate that clonal deletion IS not the
cause of the observed donor specific CML-NR
DISCUSSION
Lymphocytes from patients with a well functioning
graft may display an atasence of cytotoxic potential in
vitro towards the splenocytes of their specific kidney
donor (1-11) We have previously analyzed the cytolytic
activity of recipients' lymphocytes towards a pool of ran-
domly selected stimulator cells, and found that the ab-
sence of CML reactivity of recipients' lymphocytes was
observed not only agamst specific kidney donor cells but
also agamst some mdividual target cells from the pool
(20) Investigation of these target cells revealed a sys-
tematic absence of cytolytic activity against target cells
that partially shared HLA antigens with the specific kid-
ney donor(20)
In this study, the influence of the HLA System on the
spectrum of the in vitro cell-mediated cytotoxic responses
of posttransplant recipients' lymphocytes are descnbed
Immunogenetic analyses of the CML results obtained
with the lymphocytes from 16 recipients who had re-
ceived a renal allograft from an unrelated donor show
that selected stimulator cells may induce donor-specific
CML-NR (Tables III and IV)
All patients were able to exhibit normal effector cell
funchon after in vitro Stimulation with mismatched lym-
phocytes vs the kidney donor for the HLA-B (or -B and -
C) antigens (l e , stimulator cells 6 to 9) Some positive
reactions have been observed with stimulator cells 5
Apparently mismatchmg for the HLA-C locus products
seemed to lead to positive reactions in some cases, there-
fore additional matching for HLA-C antigens seemed to
be necessary in some cases but not in others The additive
effect of matching of HLA-C to matching for HLA-B an-
tigens on the CML response is remarkable (Table V)
Sharing of HLA-A or HLA-A and -C antigens with the
specific kidney donor resulted in almost all combinations
in the generation of cytotoxic effector cells Conse-
quently the presence of kidney donor-spec lf IC HLA-B
(and C) antigens on stimulator cells from healthy unre-
lated mdividuals leads to the absence of the generation
oi CTL (Table VI) These results clearly demonstrate the
influence of the HLA-B region products on the posttrans
plant donor-specific CML-NR Because stimulator cells
that share the HLA-B or HLA-B and -C antigens with the
kidney donor are associated with the inductin of donor-
specific CML-NR, whereas HLA-B region dispanty be-
tween the stimulator cells and the kidney donor is asso
lcated with CML activity, lt appears that the genetic
region between HLA-B and -C is involved in the induction
of CML-NR posttransplantation Consequently, the im-
munogenetic analyses of the CML-NR Status of renal
allografted patients demonstrate not only a lack of re-
sponse against kidney donor-type HLA-B antigens but a
more profound immunoregulation that prohibits the re-
sponse against other loci
Clonal deletion of these donor-directed CTL might be
one of the mechamsms accountmg for this in vitro-ob
served CML-NR, and might also be responsible for the
graft tolerance Clonal deletion is not a hkely cause of the
observed absence of cytolytic activity We observed a
significant increase of specific cytotoxic activity of CML-
NR lymphocytes after explanding of the 6 day effector
cells cultures by IL 2 (Table VII) Limiting diluüon assays
have to be carned out to determine the exact number of
circulating donor directed CTL Apparently, in vivo graft
tolerance and in vitro CML-NR exist in the presence of a
strongly decreased number of donor-directed CTL, be-
cause the addition of exogenous IL 2 resulted in prohfer-
ation and differentiation of these donor directed CTL
It might be possible that the CML nonreactivity to the
donor's alloantigens could be abrogated For example in
the case of viral infections, the decreased number of
circulating donor directed CTL could be activated, even-
tually leading to graft damage
Our observations differ from the results of Pfeffer et
al (21), who reported an in vivo depletion of donor-
specific cytotoxic cells in patients with well functioning
kidney allografts from HLA disparate related donors,
which could not be additionally activated in vitro How-
ever, the latter authors used a different protocol to ex-
pand the anti-donor-specific clones ι e , exogenous Τ cell
growth factor was added to the cultures during the in-
duction phase of the effector cells, which did not result
in augmentation of the donor-specific cytotoxic activity
In view of the discussion on clonal deletion it has to be
stressed that in this study, the immunogenetic analysis
of the CML-NR status has been concentrated on the CTL
responses towards HLA class I antigens Information
concermng pre and postrenal transplant CTL activity
against HLA class II antigens is fairly hmited
Another possible explanation that might influence the
occurrence of HLA-B (or -B and -C)-dependent CML non
responsiveness could be that strongly dimimshed prohf
eration influences the development of cytotoxic effector
cells Therefore, all responder/stimulator cell combina
tions have been checked for proliferative capacity by
means of [3H]thymidine uptake No correlation was found
between the Stimulation index in MLC and the presence
or absence of cytotoxic Τ cells (Table VIII) The latter
observation is in agreement with studies reported by
others (9 13 22)
The exact mechamsm(s) of the donor-specific HLA
dependent CML nonresponsivcness is not olear The di-
mimshed number of donor-specific HLA-B-dependent
cytotoxic Τ cell clones observed in renal allograited pa-
tients could be explained by the action oi specific sup
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REFERENCESTABLE VIII
Absence qf correlation between proliferatwe capacity and cytotoxw
actwity ofthe same responder/stimulator cell combination
Responder Stimulator
Cells Cells
P7° Kidney donor
1
2
3
4
5
6
7
8
9
Proliferative
Capacitya
8614
23 455
43 489
21 062
22 347
19 370
19 178
38 988
17 598
35 316
CTL Artivityb
9
2
7
0
0
1
4 8
56
54
38
" The means of [3H]thymidine uptake from tnphcate cultures
6
 Percentage of specifIC lysis at an effector target ratio of 50 1
c
 P7 = patient no 7
pressor cells or by anti-idiotypic antibodies. First, sup-
pressor cells responsible for the CML-NR, as manifested
in the kidney allograft tolerant Situation, have been doc-
umented in several reports (11-13). Second, evidence has
been presented by Miyajima et al. (14) for the presence of
anti-idiotypic antibodies; these authors demonstrated the
inhibitory activity of patients' sera on the proliferative
response in mixed lymphocyte reactions. Similarly, Sin-
gal and Joseph (15) described the induction IgG anti-
bodies by blood transfusion directed against the recog-
nition Sites of the responder Τ lymphocytes. According to
the latter authors (15), the antibodies capable of inhibit-
ing responses in MLC could be induced by blood trans-
fusion. The specif ic antibodies inhibiting responses in
MLC against antigens present in the kidney donor were
demonstrated in renal transplant patients with func-
tional allografts, but not in patients who rejected the
transplant. In these reports (14, 15), the antibodies were
capable of inhibiting proliferative responses against the
kidney donor HLA-B antigens and against stimulator
cells which shared the kidney donor HLA-B antigens.
These observations are striking, because in our immu-
nogenetic studies, lt was found that the occurrence of
kidney donor-specific CML-NR apparently depends on
the kidney donor HLA-B (or HLA-B and C) antigens. The
mechanism underlying this in vitro-observed state of
tolerance induced by the HLA-B (and -C) region described
in this article encompasses most probably a combination
of both the cellular and the humoral arms of the immune
regulatory System. Α large body of Information concern-
mg this topic has been obtained in animal studies (23).
Recently, evidence has been presented for the presence
and funetion of anti-idiotypic Τ cells in renal allografted
rats with prolonged graft survival (24).
It would seem important to evaluate whether the same
state of tolerance, as observed in CML after kidney trans-
plantation, can also be obtained after blood transfusion.
If that would be the case, selection of cadaveric kidney
donors for pretransplant-transfused potential reeipients
to ensure good kidney graft survival could become much
more likely.
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